[Federal Register Volume 79, Number 54 (Thursday, March 20, 2014)]
[Notices]
[Pages 15593-15594]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-06019]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 78 FR 79697-79699, dated December 31, 2013) is
amended to reflect the reorganization of the Division of Diabetes
Translation, National Center for Chronic Disease Prevention and Health
Promotion, Centers for Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the title and the mission and function
statements for the Division of Diabetes Translation (CUCG) and insert
the following:
Division of Diabetes Translation (CUCG). In collaboration with
NCCDPHP divisions, other CDC components, other HHS agencies, state,
tribal, local and territorial government agencies, academic
institutions, and voluntary and private sector organizations, the
Division of Diabetes Translation; (1) plans, directs, and coordinates a
national program to prevent diabetes and reduce morbidity, mortality,
disability, and cost associated with diabetes and its complications;
(2) identifies, evaluates, and implements programs and policies to
prevent and control diabetes through the translation of evidence-based
models and interventions for improved health care and self-care
practices into widespread clinical and community practice; (3) conducts
surveillance of diabetes, its complications, and the utilization of
health care and prevention resources to monitor trends and evaluate
program impact on morbidity, mortality, disability, and cost; (4)
conducts epidemiologic studies and disseminates finding to identify and
evaluate the feasibility and effectiveness of potential prevention and
control strategies at the community level; (5) develops or supports
clinical and public health guidelines and strategies to form the basis
for community interventions; and (6) provides technical consultation
and assistance to national, state and local organizations to implement
and evaluate cost effective interventions to reduce morbidity,
mortality, and disability.
Office of the Director (CUCG1). (1) Establishes and interprets
policies and determines program priorities; (2) provides leadership and
guidance in strategic planning, budget formulation, programmatic and
scientific planning, development, and management, administrative
management and operations of the division; (3) coordinates the
monitoring and reporting of division priorities, accomplishments,
future directions, and resource requirements; (4) leads and coordinates
policy, communications and partnership activities; and (5) coordinates
division activities with other components of NCCDPHP and CDC,
organizations in the public and private sectors, and other federal
agencies.
Epidemiology and Statistics Branch (CUCGB). (1) Conducts national
surveillance of diabetes and its complications, including surveillance
of the degree of diffusion and dissemination of preventive services and
the utilization of health care; (2) identifies clinical, health
services, and public health research findings and technologies that
have potential to prevent or control diabetes and its complications
through public health avenues; (3) develops and analyzes mathematical
and economic models to project the burden of diabetes and prioritize
effective interventions to prevent and control diabetes; (4) conducts
epidemiologic studies to identify high-risk population groups and other
risk factors for diabetes and its complications; (5) conducts cost and
cost-effectiveness analyses of diabetes prevention and control to
prioritize strategies for policy-makers; (6) provides scientific and
technical support to division staff, state and local health agencies,
and others in planning and implementation of surveillance and
effectiveness studies to reduce morbidity and mortality from diabetes;
and (7) collaborates with counterparts in other divisions, academic
institutions, and other HHS agencies by conducting national public
health research projects and by providing technical assistance in areas
of epidemiology, surveillance, and economics.
Program Implementation Branch (CUCGC). (1) Provides programmatic
leadership, guidance and consultation on a range of strategies to
improve diabetes prevention and control programs in states,
territories, tribes, and local jurisdictions; (2) identifies, develops,
implements and evaluates strategies to prevent and control diabetes
through widespread community practice and through the application of
policy and environmental interventions, health systems interventions
and community interventions; (3) provides leadership, management and
oversight for the National Diabetes Prevention Program; (4) develops,
implements and supports work with vulnerable and disparate population
groups and (5) coordinates and collaborates with counterparts in other
divisions, HHS agencies, academic institutions, and national and
voluntary organizations to improve public health diabetes prevention
and control programs, practices and policies.
Translation, Health Education, and Evaluation Branch (CUCGD). (1)
Synthesizes and translates a body of best science and practice that can
be applied to various public health settings; (2) Analyzes,
disseminates, and publishes data from diabetes prevention and control
programs to develop operational strategies for translation of results
into improved practice; (3) prepares and disseminates products that
translate applied research, program evaluation, and health economics
science to state programs and others; (4) provides technical assistance
and implementation support for evidence-based and practice-based
communication strategies, including web management, that advance
diabetes prevention and control; (5) designs, evaluates and implements
national education strategies directed toward health care professionals
and systems, individuals with and at risk for diabetes, community
leaders, business, and general public; (6) evaluates program policies,
plans, procedures, priorities,
[[Page 15594]]
and guidelines being implemented in the field to improve health,
prevent or delay type 2 diabetes and reduce morbidity, mortality,
disability and costs associated with diabetes and its complications;
and (7) provides evaluation support for division programs, grants, and
policies, including the design and evaluation of data collection
instruments for evaluation of programs.
Dated: March 12, 2014.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2014-06019 Filed 3-19-14; 8:45 am]
BILLING CODE 4160-18-M